Skip to main content
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 2025 Jan 23;380(1918):20230511. doi: 10.1098/rstb.2023.0511

Immune regulation of host energy metabolism and periodicity of malaria parasites

Isabella Cristina Hirako 1, Theresa Ramalho 2, Ricardo Tostes Gazzinelli 1,2,3,4,
PMCID: PMC11753876  PMID: 39842477

Abstract

The synchronization of Plasmodium parasites as they replicate within red blood cells of their vertebrate host remains largely unexplored. Understanding this synchronization could reveal how parasites optimize their lifecycle to maximize transmission, evade the immune response and maximize energy acquisition. Rhythmic replication fulfils some criteria of an endogenous oscillator with time of day cues potentially provided by temperature, oxygen levels, hormones and/or nutrient availability. Recent research on a rodent malaria model has highlighted that rhythms associated with the host’s feeding/fasting cycle are a crucial factor influencing the synchronization of the erythrocytic stages of Plasmodium to the host’s circadian cycle. Innate immune responses are also rhythmic and can regulate host metabolism, suggesting that the innate immune response triggered by Plasmodium contributes to its rhythmic replication. Here, we outline how the interplay between immune responses and metabolism could influence the timing and synchronization of Plasmodium’s replication rhythm, focusing on the roles of the cytokine tumour necrosis factor, mitochondrial function and metabolites generated by the tricarboxylic acid cycle in highly activated monocytes. These processes are pivotal in controlling parasitemia and determining disease outcome, suggesting that a better understanding of energy metabolism on rhythmic host–parasite interactions may provide new insights for therapeutic interventions against malaria.

This article is part of the Theo Murphy meeting issue ‘Circadian rhythms in infection and immunity’.

Keywords: malaria, circadian cycle, Plasmodium

1. Plasmodium infection and malaria

Malaria is a deadly infectious disease caused by a protozoan parasite belonging to the Plasmodium genus within the Plasmodiidae family, part of the Apicomplexa phylum. Alongside coronavirus disease 2019 (COVID-19), acquired immunodeficiency syndrome and tuberculosis, malaria ranks among the top four killer infectious diseases in the world. Globally, in 2022, there were an estimated 241 million malaria cases reported across 85 malaria-endemic countries, of which above 90% occurred in Africa [1]. While the last few decades have seen progress in reducing malaria cases, this has stalled, with a significant increase in malaria deaths in 2020–2022 compared to the previous year, with an estimated 627 000 deaths attributed to the disruption of essential malaria services during the COVID-19 pandemic [2].

The life cycle of malaria parasites in the vertebrate host commences with the bite of a female Anopheles mosquito, which introduces sporozoites along with saliva [3]. Upon entry into the human dermis, sporozoites migrate to the liver via the bloodstream. Sporozoites invade hepatocytes, and they undergo multiplication, each producing a multitude of merozoites. Upon release into circulation, merozoites invade red blood cells, developing within parasitophorous vacuoles. This developmental process encompasses three distinct stages: the ring stage, trophozoite stage and schizont stage. Following invasion, the merozoites promptly transform into the ring stage, progressing into trophozoites, which, upon maturation, initiate replication, forming schizonts composed of merozoites. Throughout most species of Plasmodium, individual parasite cells develop into rings, trophozoites and schizonts in synchrony and transition between these stages at certain times of day [4]. Upon rupture of infected red blood cells, the newly formed merozoites are released into the bloodstream, leading to the reinvasion of red blood cells and the commencement of a new replicative cycle. This cyclic pattern of invasion and burst of infected red blood cells leads to exponential replication of the parasite and symptoms of disease, including periodic fever [5].

The first records of malaria were found in Chinese and Egyptian writings from 3000 years BC. Ancient religious and medical texts related acute fevers to the gods’ punishment and the presence of evil spirits. In the Hippocratic era, malaria was known simply as ‘the fever’. Hippocrates was the first to discard superstitions, describing the intermittent paroxysm (chills, fever and sweats), the tertian fever associated with splenomegaly [6,7]. In Ancient Greek writings, Hippocrates characterized the fever: ‘When the paroxysms fall on even days, the crises will be on even days; and when the paroxysms fall on odd days, the crises will be on odd days’ [7]. In 1880, the military physician Charles Laveran was the first person to identify parasites in the blood of patients infected with malaria. During his work in Algeria, he observed blood forms of the parasite that developed inside human red blood cells [8,9]. For discovering the etiological agent of malaria, Dr Laveran received the Nobel Prize in 1907.

In 1886, 6 years later, Camillo Golgi confirmed the findings of Laveran and elucidated the cycle of the Plasmodium in red blood cells and the temporal coincidence between recurrent chills and fever with the rupture and release of parasites into the bloodstream [10]. He formulated a malaria toxin hypothesis, proposing that toxin was released during the red blood cell rupture causing cyclical fever following the synchronous replication of the parasite [7,11]. Malaria-induced fever was applied by a professor of psychiatry and neurology in Vienna, Julius Wagner-Jaureg. Dr Wagner-Jaureg’s approach was to treat neurosyphilis mental illness by inoculating malaria parasites to raise body temperature high enough to kill the causative bacteria [12]. The malaria toxin hypothesis was validated by the discovery that components released during the synchronous rupture of erythrocytes strongly activate the innate inflammatory response and culminate in a massive release of pyrogenic cytokines, e.g. interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α). Consequently, intervals between the peaks of paroxysms coincide with the duration of the intraerythrocytic development cycle of Plasmodium infection [5,13,14]. He was awarded the Nobel Prize in 1927 for developing a method to treat paralytic dementia (an advanced stage of neurosyphilis) by inoculating malaria parasites into patients. He noted that approximately 70% of the individuals who developed high fevers were cured of syphilis. The pyrotherapy was used from 1917 to the mid-1940s, before the discovery of penicillin, employing Plasmodium vivax infection, as it produced high and prolonged fevers but was not as lethal as P. falciparum [12].

2. The role of innate immunity in the pathogenesis of malaria

Decades of research have provided an extensive understanding that the pathogenesis of malaria involves the activation of innate immune receptors, which play a crucial role in immune surveillance by detecting the presence of Plasmodium parasites and initiating protective immune responses [5]. However, the excessive activation of these receptors may also lead to a systemic inflammation and poor outcome of malaria [5,14]. These receptors, initially thought to be solely the Toll-like receptors (TLRs), are responsible for recognizing specific molecules from parasites and trigger the release of pro-inflammatory cytokines and initiate the immune response upon primary infection with microbial pathogens. However, over the last two decades, other families of innate immune receptors such as Nod-like receptors (NLRs) and inflammasomes as well as cyclic GMP-AMP synthase (cGAS), retinoic acid-inducible gene I receptor (RIGI) and C-type lectin receptors have also been implicated in sensing Plasmodium infection and been involved both in host resistance to infection and the pathogenesis of malaria [4,5,13,14].

In contrast to the antigen-specific receptors (T-cell receptors and membrane immunoglobulin) found on T and B lymphocytes, there are relatively few pattern recognition receptors (PRRs) that recognize highly conserved pathogen-associated molecular patterns (PAMPs) found in certain categories of pathogens across the microbial phylogenetic tree [15]. PAMPs are microbial structures recognized by different types of PRRs, including TLRs, NLRs, cGAS and RIGI. The distinction in the localization allows TLRs to recognize PAMPs at the endosomes or at the cell surface membrane, while mRNA and DNA sensors and NLRs are cytosolic receptors [1619]. Multiple studies have revealed the important role of these PAMPs, such as glycosylphosphatidylinositol (GPI) anchors, hemozoin and immunostimulatory nucleic acids (DNA and RNA), in the initiation of the innate immune response against human parasites P. falciparum and P. vivax as well as the animal model species of Plasmodium that infects mice [5,2027].

The activation of innate immune cells and subsequent systemic inflammation are key factors in the initial manifestations of malaria upon Plasmodium infection and influence whether severe disease develops [5,28]. The massive release of pro-inflammatory cytokines, the adhesion of infected red blood cells in capillary veins and the rupture and removal of infected red blood cells by splenic macrophages are correlated events that influence the development of major syndromes associated with malaria pathogenesis, including systemic inflammation, anaemia, jaundice, respiratory distress, metabolic acidosis, as well as cerebral and placental malaria [5,28]. If P. falciparum is left untreated, uncomplicated symptomatic malaria can quickly progress to a life-threatening disease, but individuals who are repeatedly infected develop natural acquired immunity, resulting in low parasitaemia and asymptomatic infection, without deleterious activation of innate immune cells [29].

Many parameters of the immune system, such as cytokine expression, immune cell trafficking and phagocytosis, have been shown to fluctuate in a daily fashion. Furthermore, the cells of the immune system themselves, including macrophages, natural killer cells and lymphocytes, contain intrinsic biological clocks that regulate their function, which may have important implications for health and disease [3032]. This regulation likely reflects a balance between mounting an effective response at the optimal time, while minimizing immunopathology. Recent studies in mice have highlighted that disruption of the circadian cycle of hosts increases susceptibility to both viral and bacterial infections, including foodborne and airborne pathogens [30].

3. Host circadian rhythms and periodicity of Plasmodium replication

Circadian clocks regulate biological rhythms and play a significant role in coordinating processes within cells and tissues, and organism-wide [33]. By aligning their activities with external rhythms and temporally compartmentalizing internal processes, organisms are thought to maximize their survival and reproduction and optimize the use of energy [33]. Importantly, pathogens and microbiota, including parasites, are subject to the daily rhythms of their hosts. These rhythms include metabolic activity, energy sources, hormones and immune responses, which all influence host–pathogen interactions [3032]. Clock genes in humans and other vertebrates are also involved in the regulation of the circadian timekeeping genes. The expression of clock genes, such as Period (Per1, Per2 and Per3), Cryptochrome (CRY1 and CRY2), Brain and muscle ARNT-like 1 (Bmal1) and Circadian locomotor output cycles kaput (Clock) demonstrates different patterns of response in relation to stimuli and signalling pathways. Importantly, disruption of these clock genes has a significant impact on various physiological processes and systems [33].

Host daily rhythms may have a significant impact on the behaviour and physiology of parasites that influences their ability to infect and reproduce. For instance, Wuchereria bancrofti exhibits a circadian rhythm in migration within the vertebrate host, in which vector-infective stages (microfilaria) are released in the bloodstream during the night, when the mosquito vectors that transmit the parasite to humans are most active [4,34,35]. Similarly, host and vector rhythms can affect Plasmodium replication and transmission. For example, knockout mice lacking Bmal1 expression in GABAergic neurons, including those in the suprachiasmatic nucleus, exhibit non-rhythmic food intake, diminished hypoglycaemia at 6 am (ZT 23) and 12 pm (ZT 5), and disrupted synchrony of Plasmodium chabaudi in infected red blood cells [36]. Similarly, double knockout mice lacking both Per1 and Per2, which show a disrupted circadian cycle, also display disrupted synchrony of P. chabaudi cell cycle in red blood cells [37]. However, the parasite cell cycle is restored by generating a feeding/fasting rhythm by using time-restricted feeding protocols [37]. These outcomes underscore the significance of host behaviour in the synchrony and timing of P. chabaudi cell cycle in the vertebrate host. Whether evolutionary pressures driving malaria parasites to adapt to the host circadian cycle aim to enhance parasite transmission, evade the host immune response, respond to resource availability, or achieve all these benefits remains unknown.

4. Time keeping by Plasmodium

Periodicity in different parasite stages occurs across a range of taxonomic groups. The life-threatening disease sleeping sickness caused by Trypanosoma brucei causes disruption to the host’s circadian cycle, advancing the time of day of sleeping [38]. T. brucei also has a circadian cycle that drives metabolic rhythms in two different stages of the life cycle: mammalian bloodstream and insect procyclic forms [39,40]. These rhythmic patterns are influenced by the external environment, such as light–dark and feeding–fasting cycles, and the parasite’s endogenous oscillator that drives rhythmic expression of approximately 10% of genes in T. brucei in in vitro conditions. These genes are associated with regulating cellular metabolism pathways, coinciding with fluctuations in intracellular adenosine triphosphate concentration [41]. Similarly, the migration of microfilariae, described above, between the bloodstream and tissues is sensitive to the daily rhythm in the level of oxygen in the host’s blood. For example, microfilariae migrate from the pulmonary capillary barrier to peripheral blood when the level of oxygen in the pulmonary artery and vein drop below 55 mm Hg [35]. This drop occurs at night when human hosts are resting, providing a cue for the nocturnal biting activity of their mosquito vector. However, in regions without nocturnal vectors, such as Polynesia and parts of Southeast Asia, the migration rhythm of the parasite varies, which may be explained by a single, dominant mutation in an internal clock [34,42,43]. However, an endogenous oscillator in Wuchereria is yet to be found, and the parasite might simply respond directly to changes in blood oxygen tension (called a ‘just in time’ strategy).

Recent progress has been made in uncovering Plasmodium synchronization and timekeeping [4,44]. The rodent parasite, P. chabaudi, is considered the species whose infection dynamics in host and vector most closely resemble P. falciparum, the primary species that infects humans [45]. Additionally, a notable advantage is that P. chabaudi’s replication cycle lasts 24 h, which mirrors the host’s circadian rhythm, making it easier to correlate rhythmic phenotypes of parasite and host than for human-infecting Plasmodium whose cycles last 48 or 72 h. For example, 57% of P. chabaudi genes follow approximately 24 h (‘daily’) rhythms in expression, and half of these genes lose their transcription rhythm when the parasite replicates 12 h out of synchrony with host rhythms [46]. This loss of gene expression rhythmicity could disrupt the essential process of different replication stages, particularly trophozoites, which engage in vigorous replication, leading to the accumulation of biological mass and consequently, a heightened metabolic ratio. Rijo-Ferreira et al. [47] provide further support for an intrinsic clock in P. chabaudi, revealing that in hosts housed in an arrhythmic environment (constant darkness) and mutant hosts with disrupted circadian clocks, rhythmic replication is maintained for several cycles. As is typical for non-model systems, identifying clock genes is extremely challenging, although an E-box DNA motif that is a binding site of CLOCK:BMAL1, the transcriptional activator complex in the core circadian clock mechanism in mammals, might be part of Plasmodium’s intrinsic oscillator [47,48].

5. Rhythmic in-host drivers of Plasmodium periodicity

(a). Fever

IL-1β was first discovered for its property as a pyrogenic cytokine (termed leukocytic or endogenous pyrogen). TNF is pyrogenic, but a concentration of at least 20−50 times higher is needed to produce the same fever as 10 ngkg-1 IL-1β [4951]. Importantly, both IL-1β and TNF-α are pyrogenic cytokines produced in high levels by phagocytes that are activated during Plasmodium infection, both in humans and mice [22,24,5254]. The interaction of these pro-inflammatory cytokines with the anterior hypothalamus disrupts the normal thermoregulatory process. This disruption leads to an elevation in the set point of thermoregulation, causing fever [50]. IL-1β and TNF-α bind to receptors on hypothalamic neurons, triggering the synthesis of prostaglandin E2, which acts via the EP3 receptor to affect hypothalamic neurons that regulate thermoregulation, ultimately leading to the manifestation of fever [50,55].

P. falciparum loses synchrony in replication when maintained in in vitro cultures [5658], suggesting they need a rhythmic time of day cue (or Zeitgeber) to regulate the timing and synchrony of the replication rhythm. Early work suggests fever regulates P. falciparum synchrony because exposure to a temperature of 40°C inhibits parasite growth when erythrocytes are cultured in vitro [58,59]. Furthermore, initially asynchronous cultures synchronize when subjected to a temperature of 40°C on alternate days, simulating the 48 h fever cycle of P. falciparum malaria [60]. The febrile response damages developing schizonts, selectively favouring the survival of young progeny (merozoites ring stage). Thus, regular exposure to elevated temperatures, as occurs in natural infections, is likely capable of synchronizing Plasmodium replication.

However, during malaria, fever can significantly impact and disturb the normal diurnal rhythms, causing fluctuations in the patient’s body temperature ranging from 37 to 40°C. Thus, whether fever is a reliable time cue or synchronizing force throughout infections is unknown. Other open questions include what causes the parasite to replicate synchronously enough in the first place to elicit a strong fever response [4]. Furthermore, the involvement of other host rhythms is likely necessary to prevent parasites from replicating faster and faster in subsequent cycles (because slow-developing parasites are damaged by fever). Another puzzle is that mice in research institutions are kept at 20–22°C and do not exhibit fever in response to Plasmodium infection, yet the parasite still synchronizes to the host’s rhythm [4,61]. Therefore, recent research has considered other host factors that might be responsible for Plasmodiums synchronized replication in the vertebrate host.

(b). Melatonin

An important circadian pacemaker synthesized by the pineal gland in the brain is the hormone melatonin. In humans, melatonin peaks in the early hours of the dark period, regulating sleeping patterns and other circadian rhythms. Application of melatonin to in vitro cultures of P. falciparum can increase the number of schizonts [44,62]. Melatonin stimulates the release of intracellular calcium and cAMP signalling cascades in the parasite that are essential for the growth and differentiation of parasite developmental stages. This has led to the suggestion that melatonin synchronizes the replication cycle in vitro [63].

Supporting observations include that exposure of P. chabaudi or P. falciparum to melatonin accelerates the developmental process towards schizont and parasite proliferation [64]. Replication becomes less synchronous in hosts whose pineal glands are removed, but this can be ameliorated by administering melatonin injections at night [64]. However, certain inbred mouse strains, such as C57BL/6 and BALB/c, lack the last enzymatic step needed to synthesize melatonin, yet their parasites are synchronous [65]. In addition, rodents are nocturnal and, unlike humans, in CBA and C3H mice where melatonin synthesis occurs, melatonin peaks 2 h before dawn, around 5:00 am (ZT 22). Furthermore, melatonin is also an important antioxidant, and parasites nearing the end of the replication cycle are the most vulnerable to oxidative damage. Therefore, the potential mechanism through which melatonin regulates the synchrony and timing of schizogony requires further examination [65,66].

(c). Feeding

Studies conducted by Hirako et al. [61], Prior et al. [67] and O’Donnell et al [68] add to the evidence that Plasmodium’s replication rhythm is coordinated with the host’s circadian rhythm. By altering the timing of the light–dark cycle and restricting food access to either the daytime or night-time, these studies were able to alter the timing and synchrony of P. chabaudi’s replication rhythm, even in hosts without circadian clocks. Specifically, in all conditions, the ring stage peaks are associated with the timing of torpor and hypoglycaemia of the host while it is in the fasting phase of its foraging rhythm. Furthermore, the elevated glucose levels in chemically induced diabetic mice (i.e. via pancreatic β-cell destruction) reduce the synchrony of replicating parasites. A recent study confirms that the intake of food per se into the host’s body does not influence the replication rhythm [47], supporting a role for a rhythm associated with the availability of nutrients in the blood [63,69]. Hence, these studies reveal that the synchrony and timing of the parasite’s replication rhythm is aligned with daily rhythms associated with the digestion and metabolism of food rather than the light schedule [4,61,67,70,71].

Our main hypothesis builds on the knowledge that Plasmodium spp. do not have the enzymes involved in gluconeogenesis, which are entirely dependent on host glucose as the immediate source of energy for replication and biomass acquisition [72]. Indeed, glucose in vitro restriction induces parasite stasis, whereas P. falciparum does not survive in the absence of glucose [7375]. Indeed, during the intraerythrocytic stage, P. falciparum depends on glycolysis for ATP generation. Since it has no energy stores and lacks the machinery for gluconeogenesis, a continuous supply of glucose is necessary for the parasite’s growth and replication. Consistently, Saliba and colleagues demonstrated that when inhibiting glycolysis with 2-deoxy-D-glucose (2-DG) and 2-DG drugs, parasite growth is inhibited [74]. In addition to relying on the host for glucose provision, certain amino acids and vitamins are also essential for Plasmodium to complete replication. Some of these factors, to some extent, can be scavenged by the parasite as it digests haemoglobin during its development [76]. However, the amino acid isoleucine is absent in human haemoglobin and at a low frequency in murine haemoglobin and may also regulate the parasite’s replication rhythm [77]. Isoleucine may also serve as a time-of-day cue used by the parasite to align its replication rhythm to the availability of glucose, amino acids and other essential nutrients that are most abundant during the host’s active phase [77].

6. Immunometabolism as a regulator of Plasmodium periodicity

(a). TNF-induced hypoglycaemia

Kwiatkowski et al. [78] investigated TNF levels in the plasma of Gambian children infected with P. falciparum and its correlation with schizont rupture. This study indicated that TNF release, akin to fever, is paroxysmal, with a massive cytokine release occurring when a critical number of schizonts rupture simultaneously, stimulating monocytes and contributing to severe malaria pathology [78]. Consistently, TNF has been identified as a pivotal cytokine governing glucose metabolism and host energy regulation, thereby influencing disease manifestations in a murine model of malaria [36,69].

The first link between host metabolism and immune responses was suggested by a reduction in synchrony of P. chabaudi’s replication rhythm in mice lacking the TNF receptor that display attenuated hypoglycaemia [61]. Similarly, observations support the hypothesis that parasite replication is augmented under conditions of elevated blood glucose levels in humans. First, re-feeding hospitalized patients in Africa often results in malaria attacks [79]. Second, a large case–control study reported that individuals with type 2 diabetes mellitus in Kumasi, Ghana, exhibited a higher susceptibility to P. falciparum infection [80]. However, it was hypothesized that this vulnerability was due to altered olfactory signals, including expiration, in diabetic individuals, potentially leading to increased mosquito attraction and subsequent transmission [81] rather than different within-host dynamics. Third, severe malaria in children is associated with insulin resistance as indicated by delayed glucose uptake [82]. These different patterns of disease progression could be associated with rhythms in food intake and immunometabolism.

Studies performed in our laboratory and elsewhere indicate that during Plasmodium infection, in both humans and murine models, activated monocytes show enhanced glucose uptake, increased mitochondrial and tricarboxylic acid cycle activities, and upregulated expression of pro-inflammatory genes [21,36,61,83,84]. Our findings are aligned with those from Kwiatkowski et al. [78], by revealing a peak of TNF levels in the mouse blood after midnight, when the synchronized rupture of red blood cells containing schizonts occurs [61]. Furthermore, TNF signalling amplifies glucose uptake by hepatic and splenic monocytes while concurrently suppressing physical activity, food consumption, energy expenditure and clinical symptoms of disease [36]. This increased glucose metabolic rate and altered energy metabolism coincide with hypoglycaemia in the early hours of the host’s resting phase, which is accompanied by a predominance of the low-energy-consuming Plasmodium stage (rings and early trophozoites) within infected red blood cells [61]. The correlations between immune cell metabolism, host feeding/fasting and parasite developmental stage suggest that parasites are constrained in their development and biomass accumulation during the host’s resting phase, so they remain as rings stages.

We also found that monocyte-derived dendritic cells (MO-DCs), both in the liver and spleen, are main up-takers of glucose during the systemic inflammation elicited by Plasmodium infection in mice [36]. Furthermore, this enhanced glucose uptake and metabolism by MO-DCs is mediated by interferon-gamma (IFNγ)/TNF-induced expression of glucose transporter 1 [21,36]. We hypothesize that while the host immune response is not exclusively responsible for synchronization of Plasmodium’s replication rhythm, it plays an important role by promoting glucose uptake by MO-DCs, and thus, lowering circulating glucose in a TNF-dependent manner. Several studies have reported that diet restriction limits parasite replication, attenuating disease in malaria mouse models [70,71]. MO-DCs are also involved in the pathogenesis of other experimental models of malaria, such as acute respiratory distress syndrome. These cells are high producers of TNF and contribute to peripheral glucose consumption, which controls the rhythm of parasite proliferation in acutely infected mice (figure 1).

Figure 1.

MO-DCs contribute to peripheral glucose consumption, which controls the rhythm of parasite proliferation in acutely infected mice.

MO-DCs contribute to peripheral glucose consumption, which controls the rhythm of parasite proliferation in acutely infected mice. Infection with Plasmodium berghei ANKA strain leads to an IFN-γ-dependent differentiation of inflammatory monocytes into splenic MO-DCs (lower insert). Once differentiated, these MO-DCs migrate to the brain in response to CCR5 ligands, recruiting CD8+ T cells, which promote the development of experimental cerebral malaria (insert in the top left). In addition, in mice infected with P. berghei NK65 differentiated Tip-DCs emerge in the lung in a CCR4-dependent manner and mediate acute respiratory distress syndrome (ARDS). Finally, in P. chabaudi-infected mice, MO-DCs produce high amounts of TNF that affect various rhythmic parameters of host energy metabolism, such as physical activity, food intake, energy expenditure and respiratory exchange.

7. Concluding remarks

The erythrocytic stage of P. chabaudi has a 24 h cell cycle that is aligned with the host circadian cycle. We emphasize how P. chabaudi synchronization is primarily determined by host cues, rather than an intrinsic clock of the parasite on its own. In particular, that parasite cell cycle is aligned with the daily rhythms of host feeding. We hypothesize that parasite dormancy, differentiation and replication are aligned with nutrient availability during the 24 h period of the host. Because Plasmodium parasites are entirely dependent on host glucose, we conjecture that raising glucose levels in the blood soon after feeding allows parasite replication when the host is hypoglycaemic. Intriguingly, we speculate that the inflammatory response elicited by the parasite also has a central role in this process, as TNF is an important regulator of host energy metabolism and promotes hypoglycaemia during acute infection with P. chabaudi. Hence, a better understanding of the role of glucose metabolism on the host–parasite interface may provide new insights for therapeutic intervention during malaria.

Acknowledgements

We thank the US NIH (R01NS098747, R01AI079293 and R21 AI150546), the Brazilian National Institute of Science and Technology for vaccines (INCT/CNPq), the Fundação de Pesquisa do Estado de Minas Gerais (465293/2014-0) and the Fundação de Amparo de Pesquisa do Estado de São Paulo (2016/23618-8).

Contributor Information

Isabella Cristina Hirako, Email: isabellach70@hotmail.com.

Theresa Ramalho, Email: theresa.ramalho@umassmed.edu.

Ricardo Tostes Gazzinelli, Email: ricardo.gazzinelli@umassmed.edu; ricardo.gazzinelli@fiocruz.br.

Ethics

This work did not require ethical approval from a human subject or animal welfare committee.

Data accessibility

This article has no additional data.

Declaration of AI use

We have not used AI-assisted technologies in creating this article.

Authors’ contributions

I.C.H.: conceptualization, writing—original draft, writing—review and editing; T.R.: writing—original draft, writing—review and editing; R.T.G.: conceptualization, funding acquisition, project administration, supervision, writing—original draft, writing—review and editing.

All authors gave final approval for publication and agreed to be held accountable for the work performed therein.

Conflict of interest declaration

We declare we have no competing interests.

Funding

No funding has been received for this article.

References

  • 1. RBM . 2022. Partnership to end malaria. See https://endmalaria.org/.
  • 2. World Health Organization . 2023. World malaria report 2023. See https://www.who.int/publications/i/item/9789240086173.
  • 3. Michalakis Y, Renaud F. 2009. Evolution in vector control. Nature 462, 298–300. ( 10.1038/462298a) [DOI] [PubMed] [Google Scholar]
  • 4. Prior KF, Rijo-Ferreira F, Assis PA, Hirako IC, Weaver DR, Gazzinelli RT, Reece SE. 2020. Periodic parasites and daily host rhythms. Cell Host Microbe 27, 176–187. ( 10.1016/j.chom.2020.01.005) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. 2014. Innate sensing of malaria parasites. Nat. Rev. Immunol. 14, 744–757. ( 10.1038/nri3742) [DOI] [PubMed] [Google Scholar]
  • 6. Hempelmann E, Krafts K. 2013. Bad air, amulets and mosquitoes: 2,000 years of changing perspectives on malaria. Malar. J. 12, 232. ( 10.1186/1475-2875-12-232) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Cunha CB, Cunha BA. 2008. Brief history of the clinical diagnosis of malaria: from Hippocrates to Osler. J. Vector Borne Dis. 45, 194–199. [PubMed] [Google Scholar]
  • 8. Cox FE. 2010. History of the discovery of the malaria parasites and their vectors. Parasit. Vectors 3, 5. ( 10.1186/1756-3305-3-5) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Laveran CL. 1982. Classics in infectious diseases: a newly discovered parasite in the blood of patients suffering from malaria. Parasitic etiology of attacks of malaria: Charles Louis Alphonse Laveran (1845–1922). Rev. Infect. Dis. 4, 908–911. ( 10.1093/4.4.908) [DOI] [PubMed] [Google Scholar]
  • 10. Simoiu M, Codreanu R, Corlatescu AD, Pauna AM, Cilievici SE. 2023. Camillo Golgi’s impact on malaria studies. Cells 12, 2156. ( 10.3390/cells12172156) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Mazzarello P, Calligaro AL. 1998. Golgi’s documents about the history of malaria. Med. Secoli 10, 495–510. [PubMed] [Google Scholar]
  • 12. Wagner-Jauregg J, Bruetsch WL. 1946. The history of the malaria treatment of general paralysis. Am. J. Psychiatry 102, 577–582. ( 10.1176/ajp.102.5.577) [DOI] [PubMed] [Google Scholar]
  • 13. Schofield L, Grau GE. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5, 722–735. ( 10.1038/nri1686) [DOI] [PubMed] [Google Scholar]
  • 14. Antonelli LR, Junqueira C, Vinetz JM, Golenbock DT, Ferreira MU, Gazzinelli RT. 2020. The immunology of Plasmodium vivax malaria. Immunol. Rev. 293, 163–189. ( 10.1111/imr.12816) [DOI] [PubMed] [Google Scholar]
  • 15. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. 1999. Phylogenetic perspectives in innate immunity. Science 284, 1313–1318. ( 10.1126/science.284.5418.1313) [DOI] [PubMed] [Google Scholar]
  • 16. Kawai T, Ikegawa M, Ori D, Akira S. 2024. Decoding toll-like receptors: recent insights and perspectives in innate immunity. Immunity 57, 649–673. ( 10.1016/j.immuni.2024.03.004) [DOI] [PubMed] [Google Scholar]
  • 17. Motwani M, Pesiridis S, Fitzgerald KA. 2019. DNA sensing by the cGAS-STING pathway in health and disease. Nat. Rev. Genet. 20, 657–674. ( 10.1038/s41576-019-0151-1) [DOI] [PubMed] [Google Scholar]
  • 18. Brubaker SW, Bonham KS, Zanoni I, Kagan JC. 2015. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33, 257–290. ( 10.1146/annurev-immunol-032414-112240) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Broz P, Dixit VM. 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407–420. ( 10.1038/nri.2016.58) [DOI] [PubMed] [Google Scholar]
  • 20. Parroche P, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to toll-like receptor 9. Proc. Natl Acad. Sci. USA 104, 1919–1924. ( 10.1073/pnas.0608745104) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ramalho T, et al. 2024. Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cells. Cell Metab. 36, 484–497. ( 10.1016/j.cmet.2024.01.008) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kalantari P, et al. 2014. Dual engagement of the NLRP3 and AIM2 inflammasomes by Plasmodium-derived hemozoin and DNA during malaria. Cell Rep. 6, 196–210. ( 10.1016/j.celrep.2013.12.014) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Gallego-Marin C, Schrum JE, Andrade WA, Shaffer SA, Giraldo LF, Lasso AM, Kurt-Jones EA, Fitzgerald KA, Golenbock DT. 2018. Cyclic GMP-AMP synthase is the cytosolic sensor of Plasmodium falciparum genomic DNA and activates type I IFN in malaria. J. Immunol. 200, 768–774. ( 10.4049/jimmunol.1701048) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ataide MA, et al. 2014. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 10, e1003885. ( 10.1371/journal.ppat.1003885) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S, Woods AS, Gowda DC. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280, 8606–8616. ( 10.1074/jbc.M413541200) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Schofield L, Hackett F. 1993. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177, 145–153. ( 10.1084/jem.177.1.145) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Coch C, et al. 2019. Human TLR8 senses RNA from Plasmodium falciparum-infected red blood cells which is uniquely required for the IFN-γ response in NK cells. Front. Immunol. 10, 371. ( 10.3389/fimmu.2019.00371) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Miller LH, Ackerman HC, Su X-z, Wellems TE. 2013. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156–167. ( 10.1038/nm.3073) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Su XZ, Lane KD, Xia L, Sá JM, Wellems TE. 2019. Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution. Clin. Microbiol. Rev. 32, e00019-19. ( 10.1128/CMR.00019-19) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Tognini P, Thaiss CA, Elinav E, Sassone-Corsi P. 2017. Circadian coordination of antimicrobial responses. Cell Host Microbe 22, 185–192. ( 10.1016/j.chom.2017.07.007) [DOI] [PubMed] [Google Scholar]
  • 31. Curtis AM, Bellet MM, Sassone-Corsi P, O’Neill LAJ. 2014. Circadian clock proteins and immunity. Immunity 40, 178–186. ( 10.1016/j.immuni.2014.02.002) [DOI] [PubMed] [Google Scholar]
  • 32. Nakao A. 2014. Temporal regulation of cytokines by the circadian clock. J. Immunol. Res. 2014, 614529. ( 10.1155/2014/614529) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Stangherlin A, Seinkmane E, O’Neill JS. 2021. Understanding circadian regulation of mammalian cell function, protein homeostasis, and metabolism. Curr. Opin. Syst. Biol. 28, e100391. ( 10.1016/j.coisb.2021.100391) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Paily KP, Hoti SL, Das PK. 2009. A review of the complexity of biology of lymphatic filarial parasites. J. Parasit. Dis. 33, 3–12. ( 10.1007/s12639-009-0005-4) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Hawkins F. 1975. Circadian and other rhythms of parasites. Adv. Parasitol. 13, 123–182. [PubMed] [Google Scholar]
  • 36. Matteucci KC, et al. 2024. Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF-1a axis plays a key role in host resistance to Plasmodium infection. eLife. ( 10.7554/eLife.97759.1) [DOI]
  • 37. O’Donnell AJ, Prior KF, Reece SE. 2020. Host circadian clocks do not set the schedule for the within-host replication of malaria parasites. Proc. Biol. Sci. 287, 20200347. ( 10.1098/rspb.2020.0347) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Rijo-Ferreira F, Carvalho T, Afonso C, Sanches-Vaz M, Costa RM, Figueiredo LM, Takahashi JS. 2018. Sleeping sickness is a circadian disorder. Nat. Commun. 9, 62. ( 10.1038/s41467-017-02484-2) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Rijo-Ferreira F, Takahashi JS. 2020. Sleeping sickness: a tale of two clocks. Front. Cell. Infect. Microbiol. 10, 525097. ( 10.3389/fcimb.2020.525097) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Rijo-Ferreira F, Bjorness TE, Cox KH, Sonneborn A, Greene RW, Takahashi JS. 2020. Sleeping sickness disrupts the sleep-regulating adenosine system. J. Neurosci. 40, 9306–9316. ( 10.1523/JNEUROSCI.1046-20.2020) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Rijo-Ferreira F, Pinto-Neves D, Barbosa-Morais NL, Takahashi JS, Figueiredo LM. 2017. Trypanosoma brucei metabolism is under circadian control. Nat. Microbiol. 2, 17032. ( 10.1038/nmicrobiol.2017.32) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Gupta CK, Srivastava M, Murthy PK, Tyagi K, Mandal SK, Sen AB. 1990. Circadian periodicity in microfilarial counts. J. Trop. Med. Hyg. 93, 222–224. [PubMed] [Google Scholar]
  • 43. Pichon G, Treuil JP. 2004. Genetic determinism of parasitic circadian periodicity and subperiodicity in human lymphatic filariasis. C. R. Biol. 327, 1087–1094. ( 10.1016/j.crvi.2004.09.008) [DOI] [PubMed] [Google Scholar]
  • 44. Borges-Pereira L, Dias BKM, Singh MK, Garcia CRS. 2021. Malaria parasites and circadian rhythm: new insights into an old puzzle. Curr. Res. Microb. Sci. 2, 100017. ( 10.1016/j.crmicr.2020.100017) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Stephens R, Culleton RL, Lamb TJ. 2012. The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28, 73–82. ( 10.1016/j.pt.2011.10.006) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Subudhi AK, et al. 2020. Malaria parasites regulate intra-erythrocytic development duration via serpentine receptor 10 to coordinate with host rhythms. Nat. Commun. 11, 2763. ( 10.1038/s41467-020-16593-y) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Rijo-Ferreira F, Acosta-Rodriguez VA, Abel JH, Kornblum I, Bento I, Kilaru G, Klerman EB, Mota MM, Takahashi JS. 2020. The malaria parasite has an intrinsic clock. Science 368, 746–753. ( 10.1126/science.aba2658) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Smith LM, et al. 2020. An intrinsic oscillator drives the blood stage cycle of the malaria parasite Plasmodium falciparum. Science 368, 754–759. ( 10.1126/science.aba4357) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Mantovani A, Dinarello CA, Molgora M, Garlanda C. 2019. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity 50, 778–795. ( 10.1016/j.immuni.2019.03.012) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550. ( 10.1146/annurev.immunol.021908.132612) [DOI] [PubMed] [Google Scholar]
  • 51. Grau GE, Piguet PF, Vassalli P, Lambert PH. 1989. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112, 49–70. ( 10.1111/j.1600-065x.1989.tb00552.x) [DOI] [PubMed] [Google Scholar]
  • 52. Franklin BS, et al. 2009. Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc. Natl Acad. Sci. USA 106, 5789–5794. ( 10.1073/pnas.0809742106) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Hirako IC, et al. 2015. DNA-containing immunocomplexes promote inflammasome assembly and release of pyrogenic cytokines by CD14+ CD16+ CD64high CD32low inflammatory monocytes from malaria patients. mBio 6, e01605-15. ( 10.1128/mBio.01605-15) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl Acad. Sci. USA 89, 3200–3203. ( 10.1073/pnas.89.8.3200) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Cunningham ET Jr, De Souza EB. 1993. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today 14, 171–176. ( 10.1016/0167-5699(93)90281-o) [DOI] [PubMed] [Google Scholar]
  • 56. Trager W, Jensen JB. 1976. Human malaria parasites in continuous culture. Science 193, 673–675. ( 10.1126/science.781840) [DOI] [PubMed] [Google Scholar]
  • 57. Lambros C, Vanderberg JP. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65, 418–420. [PubMed] [Google Scholar]
  • 58. Pavithra SR, Banumathy G, Joy O, Singh V, Tatu U. 2004. Recurrent fever promotes Plasmodium falciparum development in human erythrocytes. J. Biol. Chem. 279, 46692–46699. ( 10.1074/jbc.M409165200) [DOI] [PubMed] [Google Scholar]
  • 59. Kwiatkowski D. 1989. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J. Exp. Med. 169, 357–361. ( 10.1084/jem.169.1.357) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Kwiatkowski D, Greenwood BM. 1989. Why is malaria fever periodic? A hypothesis. Parasitol. Today 5, 264–266. ( 10.1016/0169-4758(89)90261-5) [DOI] [PubMed] [Google Scholar]
  • 61. Hirako IC, Assis PA, Hojo-Souza NS, Reed G, Nakaya H, Golenbock DT, Coimbra RS, Gazzinelli RT. 2018. Daily rhythms of TNFα expression and food intake regulate synchrony of Plasmodium stages with the host circadian cycle. Cell Host Microbe 23, 796–808. ( 10.1016/j.chom.2018.04.016) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Dias BKM, et al. 2020. The Plasmodium falciparum eIK1 kinase (PfeIK1) is central for melatonin synchronization in the human malaria parasite. Melatotosil blocks melatonin action on parasite cell cycle. J. Pineal Res. 69, e12685. ( 10.1111/jpi.12685) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Lima WR, Tessarin-Almeida G, Rozanski A, Parreira KS, Moraes MS, Martins DC, Hashimoto RF, Galante PAF, Garcia CRS. 2016. Signaling transcript profile of the asexual intraerythrocytic development cycle of Plasmodium falciparum induced by melatonin and cAMP. Genes Cancer 7, 323–339. ( 10.18632/genesandcancer.118) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Hotta CT, Gazarini ML, Beraldo FH, Varotti FP, Lopes C, Markus RP, Pozzan T, Garcia CR. 2000. Calcium-dependent modulation by melatonin of the circadian rhythm in malarial parasites. Nat. Cell. Biol. 2, 466–468. ( 10.1038/35017112) [DOI] [PubMed] [Google Scholar]
  • 65. Kennaway DJ, Voultsios A, Varcoe TJ, Moyer RW. 2002. Melatonin in mice: rhythms, response to light, adrenergic stimulation, and metabolism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R358–65. ( 10.1152/ajpregu.00360.2001) [DOI] [PubMed] [Google Scholar]
  • 66. Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, Parry BL, Revell VL. 2008. Measuring melatonin in humans. J. Clin. Sleep Med 4, 66–69. ( 10.5664/jcsm.27083) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Prior KF, et al. 2018. Timing of host feeding drives rhythms in parasite replication. PLoS Pathog. 14, e1006900. ( 10.1371/journal.ppat.1006900) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. O’Donnell AJ, Greischar MA, Reece SE. 2022. Mistimed malaria parasites re-synchronize with host feeding-fasting rhythms by shortening the duration of intra-erythrocytic development. Parasite Immunol. 44, e12898. ( 10.1111/pim.12898) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Evans DA, Jacobs DO, Wilmore DW. 1989. Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am. J. Physiol. 257, R1182–9. ( 10.1152/ajpregu.1989.257.5.R1182) [DOI] [PubMed] [Google Scholar]
  • 70. Mancio-Silva L, et al. 2017. Nutrient sensing modulates malaria parasite virulence. Nature 547, 213–216. ( 10.1038/nature23009) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Mejia P, et al. 2015. Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression. Nat. Commun. 6, 6050. ( 10.1038/ncomms7050) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Salcedo-Sora JE, Caamano-Gutierrez E, Ward SA, Biagini GA. 2014. The proliferating cell hypothesis: a metabolic framework for Plasmodium growth and development. Trends Parasitol. 30, 170–175. ( 10.1016/j.pt.2014.02.001) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Srivastava A, Philip N, Hughes KR, Georgiou K, MacRae JI, Barrett MP, Creek DJ, McConville MJ, Waters AP. 2016. Stage-specific changes in Plasmodium metabolism required for differentiation and adaptation to different host and vector environments. PLoS Pathog. 12, e1006094. ( 10.1371/journal.ppat.1006094) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. van Schalkwyk DA, Priebe W, Saliba KJ. 2008. The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum. J. Pharmacol. Exp. Ther. 327, 511–517. ( 10.1124/jpet.108.141929) [DOI] [PubMed] [Google Scholar]
  • 75. Joet T, Eckstein-Ludwig U, Morin C, Krishna S. 2003. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Proc. Natl Acad. Sci. USA 100, 7476–7479. ( 10.1073/pnas.1330865100) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Babbitt SE, Altenhofen L, Cobbold SA, Istvan ES, Fennell C, Doerig C, Llinás M, Goldberg DE. 2012. Plasmodium falciparum responds to amino acid starvation by entering into a hibernatory state. Proc. Natl Acad. Sci. USA 109, E3278–87. ( 10.1073/pnas.1209823109) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Prior KF, Middleton B, Owolabi ATY, Westwood ML, Holland J, O’Donnell AJ, Blackman MJ, Skene DJ, Reece SE. 2021. Synchrony between daily rhythms of malaria parasites and hosts is driven by an essential amino acid. Wellcome Open Res. 6, 186. ( 10.12688/wellcomeopenres.16894.2) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. 1989. Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin. Exp. Immunol. 77, 361–366. [PMC free article] [PubMed] [Google Scholar]
  • 79. Murray MJ, Murray NJ, Murray AB, Murray MB. 1975. Refeeding-malaria and hyperferraemia. Lancet 1, 653–654. ( 10.1016/s0140-6736(75)91758-4) [DOI] [PubMed] [Google Scholar]
  • 80. Danquah I, Bedu-Addo G, Mockenhaupt FP. 2010. Type 2 diabetes mellitus and increased risk for malaria infection. Emerg. Infect. Dis. 16, 1601–1604. ( 10.3201/eid1610.100399) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Takken W, Knols BG. 1999. Odor-mediated behavior of Afrotropical malaria mosquitoes. Annu. Rev. Entomol. 44, 131–157. ( 10.1146/annurev.ento.44.1.131) [DOI] [PubMed] [Google Scholar]
  • 82. Zijlmans W, van Kempen A, Ackermans M, de Metz J, Kager P, Sauerwein H. 2008. Glucose kinetics during fasting in young children with severe and non-severe malaria in Suriname. Am. J. Trop. Med. Hyg 79, 605–612. ( 10.4269/ajtmh.2008.79.605) [DOI] [PubMed] [Google Scholar]
  • 83. Diniz SQ, et al. 2021. Plasmodium vivax infection alters mitochondrial metabolism in human monocytes. mBio 12, e0124721. ( 10.1128/mBio.01247-21) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Antonelli LRV, et al. 2014. The CD14+CD16+ inflammatory monocyte subset displays increased mitochondrial activity and effector function during acute Plasmodium vivax malaria. PLoS Pathog. 10, e1004393. ( 10.1371/journal.ppat.1004393) [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

This article has no additional data.


Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES